Trials / Completed
CompletedNCT01001949
In Vivo Evaluation of the Physiological Effects of Arabinoxylan-oligosaccharides (AXOS) in Healthy Subjects (Juniors)
In Vivo Evaluation of the Physiological Effects of Arabinoxylan-oligosaccharides (AXOS) in Healthy Subjects: a Randomized, Placebo-controlled, Double-blind, Cross-over Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 29 (actual)
- Sponsor
- Fugeia NV · Industry
- Sex
- All
- Age
- 8 Years – 12 Years
- Healthy volunteers
- Accepted
Summary
The investigational product used in this study is a soft drink containing an arabinoxylan-oligosaccharide (AXOS) preparation extracted from wheat bran (hereafter called Wheat Bran Extract, WBE). The objective of this study is to analyze the effect of the intake of WBE on various parameters of gastrointestinal health in children (8-12 yrs). Additionally, safety was analyzed using treatment emergent Adverse Events (AEs).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Wheat Bran Extract | soft drink comprising WBE and natural flavor and coloring agent, ingestion after breakfast and after dinner |
| DIETARY_SUPPLEMENT | placebo | soft drink with natural flavor and coloring agent, without WBE, ingestion after breakfast and dinner |
Timeline
- Start date
- 2009-03-01
- Primary completion
- 2009-05-01
- Completion
- 2009-10-01
- First posted
- 2009-10-27
- Last updated
- 2009-10-27
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT01001949. Inclusion in this directory is not an endorsement.